Quercetin Nanoemulsion Ameliorates Neuronal Dysfunction in Experimental Alzheimer's Disease Model
- PMID: 36290710
- PMCID: PMC9598210
- DOI: 10.3390/antiox11101986
Quercetin Nanoemulsion Ameliorates Neuronal Dysfunction in Experimental Alzheimer's Disease Model
Abstract
Aluminum is the most abundant metal that can get admission to the human through several means that include our food, drinking water, cans, drugs, and deodorants, causing neurodegenerative diseases such as Alzheimer's disease (AD). The present study aims to evaluate the role of quercetin nanoemulsion (QCNE) in attenuating neuronal dysfunction in aluminum chloride (AlCl3)-induced experimental AD. All animals were classified into six groups including negative control group (I): received a vehicle; QC group: received intraperitoneal (IP) injection of QC; Alzheimer's group: received AlCl3 orally; treated group (I): received AlCl3 orally and IP injection of QC; treated group (II): received AlCl3 orally and QC orally; and treated group (III): received AlCl3 orally and IP injection of QCNE. At the end of the experimental period (30 days), the brain was used to study biochemical parameters (measurement of neurotransmitters (serotonin, dopamine, and norepinephrine), oxidant/antioxidant parameters (reduced glutathione, malondialdehyde, superoxide dismutase, and advanced oxidation protein product), and inflammatory markers (adiponectin, interleukin 1β, and plasma tumor necrosis factor-alpha)), while another part was for brain immune-histochemical analysis (study cyclooxygenases (COX-1 and COX-2)). Results showed that the mean value of oxidative stress markers was significantly increased in the AD group as well as the inflammatory biomarkers and all the study neurotransmitters, whereas these parameters were attenuated in treated groups, especially those that received QCNE. The immunohistochemistry findings confirm our results. Both approaches (QC and QCNE) succeeded in retracting the negative impact of AlCl3. Meanwhile, the effect of QCNE is more potent in mitigating the impact mediated by AlCl3 in treated animals. In conclusion, the treatment mainly by QCNE has huge potential in protecting against AlCl3-induced neuronal dysfunction, as shown in our results by the elevation of brain antioxidant/anti-inflammatory activities and neurotransmitter levels as well as mending of the histopathological changes in animal models.
Keywords: Alzheimer’s disease; immunohistochemistry; nanoemulsion; oxidative; quercetin; rats.
Conflict of interest statement
The authors declare that they have no conflicts of interest.
Figures




Similar articles
-
Evaluation of urinary 8-hydroxy-2-deoxyguanosine level in experimental Alzheimer's disease: Impact of carvacrol nanoparticles.Mol Biol Rep. 2019 Aug;46(4):4517-4527. doi: 10.1007/s11033-019-04907-3. Epub 2019 Jun 17. Mol Biol Rep. 2019. PMID: 31209743
-
AlCl3 induced learning and memory deficit in zebrafish.Neurotoxicology. 2022 Sep;92:67-76. doi: 10.1016/j.neuro.2022.07.004. Epub 2022 Jul 15. Neurotoxicology. 2022. PMID: 35843305
-
Isoimperatorin therapeutic effect against aluminum induced neurotoxicity in albino mice.Front Pharmacol. 2023 Apr 18;14:1103940. doi: 10.3389/fphar.2023.1103940. eCollection 2023. Front Pharmacol. 2023. PMID: 37180724 Free PMC article.
-
Celastrol and thymoquinone alleviate aluminum chloride-induced neurotoxicity: Behavioral psychomotor performance, neurotransmitter level, oxidative-inflammatory markers, and BDNF expression in rat brain.Biomed Pharmacother. 2022 Jul;151:113072. doi: 10.1016/j.biopha.2022.113072. Epub 2022 May 13. Biomed Pharmacother. 2022. PMID: 35576663
-
Myco-fabricated ZnO nanoparticles ameliorate neurotoxicity in mice model of Alzheimer's disease via acetylcholinesterase inhibition and oxidative stress reduction.Biometals. 2023 Dec;36(6):1391-1404. doi: 10.1007/s10534-023-00525-6. Epub 2023 Aug 9. Biometals. 2023. PMID: 37556014 Free PMC article.
Cited by
-
Promising Natural Remedies for Alzheimer's Disease Therapy.Molecules. 2025 Feb 17;30(4):922. doi: 10.3390/molecules30040922. Molecules. 2025. PMID: 40005231 Free PMC article. Review.
-
A review on traditional Chinese medicine natural products and acupuncture intervention for Alzheimer's disease based on the neuroinflammatory.Chin Med. 2024 Feb 28;19(1):35. doi: 10.1186/s13020-024-00900-6. Chin Med. 2024. PMID: 38419106 Free PMC article. Review.
-
Intra-nasal Delivery of Quercetin-Loaded Nanostructured Lipid Carriers (NLCs) in the Management of Alzheimer's Disease: Formulation, In Vitro and In Vivo assessment.Mol Neurobiol. 2025 Jun 10. doi: 10.1007/s12035-025-05137-4. Online ahead of print. Mol Neurobiol. 2025. PMID: 40493344
-
Recent Advances in Nanoformulations for Quercetin Delivery.Pharmaceutics. 2023 Jun 5;15(6):1656. doi: 10.3390/pharmaceutics15061656. Pharmaceutics. 2023. PMID: 37376104 Free PMC article. Review.
-
The role of quercetin in NLRP3-associated inflammation.Inflammopharmacology. 2024 Dec;32(6):3585-3610. doi: 10.1007/s10787-024-01566-0. Epub 2024 Sep 22. Inflammopharmacology. 2024. PMID: 39306817 Review.
References
-
- Prema A., Thenmozhi A.J., Manivasagam T., Essa M.M., Akbar M.D., Akbar M. Fenugreek Seed Powder Nullified Aluminium Chloride Induced Memory Loss, Biochemical Changes, Aβ Burden and Apoptosis via Regulating Akt/GSK3β Signaling Pathway. PLoS ONE. 2016;11:e01659552016. doi: 10.1371/journal.pone.0165955. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Research Materials